What is MiMedx Group's other commercial liabilities?

MiMedx Group (MDXG) reported other commercial liabilities of $11.01M in Q1 2026.

How has MiMedx Group's other commercial liabilities changed year-over-year?

MiMedx Group's other commercial liabilities increased by 16.5% year-over-year, from $9.45M to $11.01M.

What is the long-term trend for MiMedx Group's other commercial liabilities?

Over 5 years (2020 to 2025), MiMedx Group's other commercial liabilities has grown at a -17.9% compound annual growth rate (CAGR), from $30.46M to $11.38M.

MiMedx Group MDXG Other Commercial Liabilities

Other Commercial Liabilities at other companies

IAR

Integra LifeSciencesIART

——

ArtivionAORT

——

SolventumSOLV

——

VericelVCEL

——

EnovisENOV

——

Tactile Systems TechnologyTCMD

——

Other financials

Income statement

See full

Revenue$59.0M-33.1%

Gross profit$41.6M-41.9%

Operating income-$16.0M-295%

Net income-$10.9M-255%

EPS (diluted)-$0.07-240%

Balance sheet

See full

Cash & equivalents$159.8M+50.1%

Total debt$17.6M-5.7%

Total equity$242.9M+19.8%

Total assets$308.7M+14.1%

Cash flow

See full

Operating cash flow$1.9M-64.5%

CapEx$570.0K+51.2%

Free cash flow$1.3M-73.4%

Valuation

See full

Market cap$567.48M-33.9%

Enterprise value$425.3M-44.8%

P/E18.5×-2.9×

P/S1.5×-1.0×

Profitability

See full

Gross margin81%-0.9pp

Operating margin10.2%-5.1pp

Net margin7.9%-3.5pp

FCF margin17.8%-0.5pp

Returns & leverage

See full

Return on equity13.8%-8.6pp

Debt / equity0.1×0.0×

Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MiMedx Group's other commercial liabilities?: MiMedx Group (MDXG) reported other commercial liabilities of $11.01M in Q1 2026.
How has MiMedx Group's other commercial liabilities changed year-over-year?: MiMedx Group's other commercial liabilities increased by 16.5% year-over-year, from $9.45M to $11.01M.
What is the long-term trend for MiMedx Group's other commercial liabilities?: Over 5 years (2020 to 2025), MiMedx Group's other commercial liabilities has grown at a -17.9% compound annual growth rate (CAGR), from $30.46M to $11.38M.